HOME >> MEDICINE >> NEWS
Marrow injection gets damaged hearts moving

CHICAGO, Nov. 17 In one of the first studies of its kind, researchers discovered that bone marrow cells injected directly into the heart significantly enhanced function, according to findings reported today at the American Heart Association's Scientific Sessions 2002.

Heart wall contraction improved significantly after patients had their own bone marrow injected into scar tissue caused by heart attacks. Heart wall motion improved within weeks of treatment and persisted for at least 10 months after treatment in 14 patients.

"The benefit (of transplanting bone marrow into scar tissue of the heart) could be seen only six weeks after injection," says Manuel Galinanes, M.D., a heart surgeon at the University of Leicester in the United Kingdom.

The technique is a new way to strengthen heart muscle after a heart attack, he adds.

Bone marrow has been used for years to treat certain types of cancer and disorders affecting the body's disease-fighting immune system. Marrow transplantation is an attractive therapy because it can form healthy new cells. Bone marrow also has the potential to develop into many different types of cells.

"Bone marrow not only can differentiate into heart cells, but also smooth muscle cells, connective tissue cells and other types of cells to reconstitute the entire structure of a tissue," Galinanes says.

The investigators have yet to prove that bone marrow creates a new cellular infrastructure in heart scar tissue, but "that is the only possible explanation," Galinanes says.

The British team treated patients whose hearts had been severely damaged by heart attacks. All patients had low ejection fractions, meaning the heart muscle had lost much of its ability to pump blood into the circulation. The bone marrow injections were given during non-emergency coronary artery bypass surgery. Before surgery, each patient had a stress test to confirm abnormal movement in the walls of the heart muscle. The test invo
'"/>

Contact: Carole Bullock
carole.bullock@heart.org
214-706-1279
American Heart Association
17-Nov-2002


Page: 1 2 3

Related medicine news :

1. Less Toxic Bone Marrow Transplant Technique May Have More Powerful Anti-Cancer Effect
2. Organ Transplants Helped By Donor Bone Marrow, University Of Pittsburgh Researchers Report At National Transplant Meetings
3. Bone Marrow With Heart And Lung Transplants Reduces Rejection Of Transplanted Organs, Reports University Of Pittsburgh
4. Bone Marrow With Organ Transplants Reduces Rejection Of Transplanted Organs, Reports University Of Pittsburgh
5. Duke Researchers Identify New Pulmonary Syndrome Associated With Bone Marrow Transplantation For Breast Cancer
6. Medically supervised drug injection facilities safer for users
7. Study examines harm reduction among injection drug users
8. Transparent orthodontic brackets by microinjection
9. Pain relief could be easy with a simple injection
10. RFA safe for treating liver tumors pushing on GI tract; Alcohol injection makes RFA more effective
11. Naltrexone injections for alcohol dependence: once-a-month treatment helps maintain sobriety

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Marrow injection gets damaged hearts moving

(Date:7/27/2014)... The European Agricultural Adjuvants Market report ... analysis and forecast of revenue. The agricultural adjuvants market ... million in 2013 to $657.1 million by 2018, at ... Browse through the TOC of the European Agricultural Adjuvants ... analysis provided. It also provides a glimpse of the ...
(Date:7/27/2014)... (PRWEB) July 27, 2014 Metachromatic ... a lysosomal storage disease which is commonly listed ... among the sphingolipidoses as it affects the metabolism ... of myelin, the fatty covering which acts as ... and peripheral nervous systems. MLD involves cerebroside sulfate ...
(Date:7/27/2014)... One of the emerging trends I the ... Asia Pacific (APAC) region. The Diagnostics industry, in countries such ... for genomics solutions, thereby contributing to market growth. , Analysts ... a CAGR of 11.21 percent over the period 2013-2018. According ... is an increase in the demand for consumables. The growing ...
(Date:7/27/2014)... (PRWEB) July 27, 2014 Alta ... process outsourcing (BPO) for Fortune 500 brands, announced today ... across its locations in Wisconsin, California, Florida and the ... support several health-insurance clients, which have seasonal ramp-ups that ... Period (AEP), November 2014 through February 2015. As more ...
(Date:7/27/2014)... (PRWEB) July 27, 2014 Wright & ... Louisiana has filed a GranuFlo lawsuit against Fresenius ... in Louisiana over the recalled dialysis drugs GranuFlo and ... Medicaid program by not disclosing the heart attack risks ... contends that Fresenius notified its own clinics, practitioners and ...
Breaking Medicine News(10 mins):Health News:Europe Agricultural Adjuvants Market is Expected to Reach $657.1 million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Agricultural Adjuvants Market is Expected to Reach $657.1 million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Agricultural Adjuvants Market is Expected to Reach $657.1 million in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Agricultural Adjuvants Market is Expected to Reach $657.1 million in 2018 - New Report by MicroMarket Monitor 5Health News:Metachromatic Leukodystrophy Therapeutics Clinical Trials Market Review H2 2014 Report Available at LifeScienceIndustryResearch.com 2Health News:Metachromatic Leukodystrophy Therapeutics Clinical Trials Market Review H2 2014 Report Available at LifeScienceIndustryResearch.com 3Health News:Metachromatic Leukodystrophy Therapeutics Clinical Trials Market Review H2 2014 Report Available at LifeScienceIndustryResearch.com 4Health News:Metachromatic Leukodystrophy Therapeutics Clinical Trials Market Review H2 2014 Report Available at LifeScienceIndustryResearch.com 5Health News:Genomics, Single Nucleotide Polymorphism Genotyping and Analysis Market 2014 – 2018 in New Research Report at Sandlerresearch.org 2Health News:Genomics, Single Nucleotide Polymorphism Genotyping and Analysis Market 2014 – 2018 in New Research Report at Sandlerresearch.org 3Health News:Genomics, Single Nucleotide Polymorphism Genotyping and Analysis Market 2014 – 2018 in New Research Report at Sandlerresearch.org 4Health News:Genomics, Single Nucleotide Polymorphism Genotyping and Analysis Market 2014 – 2018 in New Research Report at Sandlerresearch.org 5Health News:Alta Resources to Fill Approximately 2,500 Positions 2Health News:Alta Resources to Fill Approximately 2,500 Positions 3Health News:Louisiana Files GranuFlo Lawsuit Against Fresenius Medical Care over Its Recalled GranuFlo and NaturaLyte Dialysis Drugs 2Health News:Louisiana Files GranuFlo Lawsuit Against Fresenius Medical Care over Its Recalled GranuFlo and NaturaLyte Dialysis Drugs 3Health News:Louisiana Files GranuFlo Lawsuit Against Fresenius Medical Care over Its Recalled GranuFlo and NaturaLyte Dialysis Drugs 4Health News:Louisiana Files GranuFlo Lawsuit Against Fresenius Medical Care over Its Recalled GranuFlo and NaturaLyte Dialysis Drugs 5
(Date:7/25/2014)... Research and Markets has announced the addition ... report to their offering. ... An ophthalmic diagnostic device is a ... in the human visual pathway. Ophthalmic devices are used ... glaucoma, retinal disorders, conjunctivitis, and dry eyes. ...
(Date:7/25/2014)... , July 25, 2014  AMETEK, Inc. (NYSE: ... Kurtis L. Goos as Vice President and General ... and Packaging (EMIP) Division. "I am pleased ... management and business development experience, especially in the medical ... contributions to the continued growth and success of our ...
(Date:7/25/2014)... 2014 Leading events organizer UBM Live ... the seventh year to São Paulo, Brazil ... 2014. The event will co-locate with Food Ingredients South America ... meeting point for the pharmaceutical industry.      (Logo: ... pharmaceutical sales are now exploring the South America ...
Breaking Medicine Technology:Global Ophthalmic Diagnostic Devices Market 2014-2018: Key Vendors are Alcon, Carl Zeiss, Haag-Streit and Topcon 2AMETEK Names Kurtis L. Goos, Vice President & General Manager, Engineered Medical Components 2CPhI South America 2014 Launches with Generics Showing Huge Growth 2CPhI South America 2014 Launches with Generics Showing Huge Growth 3CPhI South America 2014 Launches with Generics Showing Huge Growth 4
Cached News: